Difficulty: Medium
Average Score: 88%
Practice
Monthly injections of palivizumab, a RSV-specific monoclonal antibody, initiated just before the onset of the RSV season confers some protection from severe RSV disease. Palivizumab is indicated for some infants under 2 years old with
Correct answer
B
Rationale
Palivizumab is indicated for high-risk infants, including those born prematurely or with underlying medical conditions such as very low birth weight or cyanotic congenital heart disease.